Trimethylamine N-oxide, choline and its metabolites are associated with the risk of non-alcoholic fatty liver disease.

It is inconclusive whether trimethylamine N-oxide (TMAO) and choline and related metabolites, namely trimethylamine (TMA), l-carnitine, betaine and dimethylglycine (DMG), are associated with non-alcoholic fatty liver disease (NAFLD). Our objective was to investigate these potential associations. Additionally, we sought to determine the mediating role of TMAO. In this 1:1 age- and sex-matched case-control study, a total of 150 pairs comprising NAFLD cases and healthy controls were identified. According to the fully adjusted model, after the highest tertile was compared with the lowest tertile, the plasma TMAO concentration (OR = 2·02 (95 % CI 1·04, 3·92); P trend = 0·003), l-carnitine concentration (OR = 1·79 (1·01, 3·17); P trend = 0·020) and DMG concentration (OR = 1·81 (1·00, 3·28); P trend = 0·014) were significantly positively associated with NAFLD incidence. However, a significantly negative association was found for plasma betaine (OR = 0. 50 (0·28, 0·88); P trend = 0·001). The restricted cubic splines model consistently indicated positive dose-response relationships between exposure to TMAO, l-carnitine, and DMG and NAFLD risk, with a negative association being observed for betaine. The corresponding AUC increased significantly from 0·685 (0·626, 0·745) in the traditional risk factor model to 0·769 (0·716, 0·822) when TMAO and its precursors were included (l-carnitine, betaine and choline) (P = 0·032). Mediation analyses revealed that 14·7 and 18·6 % of the excess NAFLD risk associated with l-carnitine and DMG, respectively, was mediated by TMAO (the P values for the mediating effects were 0·021 and 0·036, respectively). These results suggest that a higher concentration of TMAO is associated with increased NAFLD risk among Chinese adults and provide evidence of the possible mediating role of TMAO.

2D/2D Bi2MoO6/CoAl LDH S-scheme heterojunction for enhanced removal of tetracycline: Performance, toxicity, and mechanism.

In this paper, the two-dimensional (2D) layered CoAl LDH (CoAl) was coupled with Bi2MoO6 (BMO) nanoplate and used for tetracycline (TC) degradation. Based on the results of UV-visible diffuse reflectance spectrum (UV-vis DRS), Motty-Schottky curves, and in situ X-ray photoelectron spectroscopy (XPS), a novel 2D/2D Bi2MoO6/CoAl LDH S-scheme heterojunction photocatalyst was built. The photodegradation rate constant of TC by the optimized sample BMO/CoAl30 was 3.637 × 10-2 min-1, which was 1.26 times and 4.01 times higher than that of Bi2MoO6 and CoAl LDH, respectively. The favorable photocatalytic performance of the heterojunction was attributed to the increased interfacial contact area of the 2D/2D structure. Besides, the transfer of photogenerated electrons from Bi2MoO6 to CoAl LDH under the effect of the built-in electric field (BIEF) reduced the recombination of photogenerated carriers and further improved the photocatalytic performance. The reactive species of h+, ·O2-, and 1O2 exhibited critical roles to degrade TC molecules by reactive radicals capture experiments and electron spin resonance (ESR) tests. The intermediate products of TC degradation and toxicity of intermediates were analyzed by liquid chromatography-mass spectrometer (LC-MS) and Toxicity Estimation Software Tool (T.E.S.T). Additionally, the BMO/CoAl composite photocatalysts showed high stability and environmental tolerance during the testing of cycles and environmental impacts with various water sources, organic contaminants, initial pH, and inorganic ions. This work provides a new protocol for designing and constructing novel 2D/2D S-scheme heterojunction photocatalysts for wastewater treatment.

Milligan-Morgan hemorrhoidectomy with anal cushion suspension and partial internal sphincter resection for circumferential mixed hemorrhoids.

AIM: To identify a more effective treatment protocol for circumferential mixed hemorrhoids. METHODS: A total of 192 patients with circumferential mixed hemorrhoids were randomized into the treatment group, where they underwent Milligan-Morgan hemorrhoidectomy with anal cushion suspension and partial internal sphincter resection, or the control group, where traditional external dissection and internal ligation were performed. Postoperative recovery and complications were monitored. RESULTS: The time to wound healing was 12.96 ± 2.25 d in the treatment group shorter than 19.58 ± 2.71 d in the control group. Slight pain rate was 58.3% in the treatment group higher than 22.9% in the control group; moderate pain rate was 33.3% in the treatment group lower than 56.3% in the control group severe pain rate was 8.4% in the treatment group lower than 20.8% in the control group. No edema rate was 70.8% in the treatment group higher than 43.8% in the control group; mild local edema rate was 26% in the treatment group lower than 39.6% in the control group obvious local edema was 3.03% in the treatment group lower than 16.7% in the control group. No stenosis rate was 85.4% in the treatment group higher than 63.5% in the control group; moderate stenosis rate was 14.6% in the treatment group Lower than 27.1% in the control group severe anal stenosis rate was 0% in the treatment group lower than 9.4% in the control group. CONCLUSION: Milligan-Morgan hemorrhoidectomy with anal cushion suspension and partial internal sphincter resection is the optimal treatment for circumferential mixed hemorrhoids and can be widely applied in clinical settings.

[Analysis on hepatitis C virus genotypes among 118 HCV-infected patients in Xinjiang region].

Not Abstract.